Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alexey M. Zadorozhny"'
Autor:
Galina V. Kochneva, Gleb A. Kudrov, Sergei S. Zainutdinov, Irina S. Shulgina, Andrei V. Shipovalov, Anna V. Zaykovskaya, Mariya B. Borgoyakova, Ekaterina V. Starostina, Sergei A. Bodnev, Galina F. Sivolobova, Antonina A. Grazhdantseva, Daria I. Ivkina, Alexey M. Zadorozhny, Larisa I. Karpenko, Oleg V. P’yankov
Publikováno v:
Vaccines, Vol 12, Iss 7, p 783 (2024)
The mouse paramyxovirus Sendai, which is capable of limited replication in human bronchial epithelial cells without causing disease, is well suited for the development of vector-based intranasal vaccines against respiratory infections, including SARS
Externí odkaz:
https://doaj.org/article/c07e7ed33441488e9b4c13fcca6b336e
Autor:
Ekaterina A. Volosnikova, Iuliia A. Merkuleva, Tatiana I. Esina, Dmitry N. Shcherbakov, Mariya B. Borgoyakova, Anastasiya A. Isaeva, Valentina S. Nesmeyanova, Natalia V. Volkova, Svetlana V. Belenkaya, Anna V. Zaykovskaya, Oleg V. Pyankov, Ekaterina V. Starostina, Alexey M. Zadorozhny, Boris N. Zaitsev, Larisa I. Karpenko, Alexander A. Ilyichev, Elena D. Danilenko
Publikováno v:
Vaccines, Vol 11, Iss 4, p 808 (2023)
Despite the rapid development and approval of several COVID vaccines based on the full-length spike protein, there is a need for safe, potent, and high-volume vaccines. Considering the predominance of the production of neutralizing antibodies targeti
Externí odkaz:
https://doaj.org/article/f1e47c9a247e478f964607cf1e5745a2
Autor:
Sergei N. Shchelkunov, Stanislav N. Yakubitskiy, Alexander A. Sergeev, Ekaterina V. Starostina, Ksenia A. Titova, Stepan A. Pyankov, Galina A. Shchelkunova, Mariya B. Borgoyakova, Alexey M. Zadorozhny, Lyubov A. Orlova, Denis N. Kisakov, Larisa I. Karpenko
Publikováno v:
Viruses, Vol 14, Iss 7, p 1453 (2022)
The conventional live smallpox vaccine based on the vaccinia virus (VACV) cannot be widely used today because it is highly reactogenic. Therefore, there is a demand for designing VACV variants possessing enhanced immunogenicity, making it possible to
Externí odkaz:
https://doaj.org/article/7c9855202119445588ad2769503afd31
Autor:
Sergei N. Shchelkunov, Alexander A. Sergeev, Stanislav N. Yakubitskiy, Ksenia A. Titova, Stepan A. Pyankov, Irina V. Kolosova, Ekaterina V. Starostina, Mariya B. Borgoyakova, Alexey M. Zadorozhny, Denis N. Kisakov, Irina S. Shulgina, Larisa I. Karpenko
Publikováno v:
Viruses, Vol 13, Iss 8, p 1631 (2021)
Mass vaccination has played a critical role in the global eradication of smallpox. Various vaccinia virus (VACV) strains, whose origin has not been clearly documented in most cases, have been used as live vaccines in different countries. These VACV s
Externí odkaz:
https://doaj.org/article/9724a2bc6d794a6287d7840378ce7ea5
Autor:
Mariya B. Borgoyakova, Larisa I. Karpenko, Ekaterina V. Starostina, Ekaterina A. Volosnikova, Alexey M. Zadorozhny, Lyubov A. Orlova, Alexander A. Ilyichev
Publikováno v:
Russian Journal of Immunology. 25:131-138
Massive vaccination against SARS-CoV-2 appears to be one of the most important steps towards solving the problem of the COVID-19 pandemic, which threatened the lives of millions of people over two and a half years. To create anti-COVID-19 vaccines, b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::febd76dc22788c3903b79b27db2a3c02
https://doi.org/10.46235/1028-7221-1114-cir
https://doi.org/10.46235/1028-7221-1114-cir
Autor:
Mariya B. Borgoyakova, Larisa I. Karpenko, Andrey P. Rudometov, Ekaterina A. Volosnikova, Iuliia A. Merkuleva, Ekaterina V. Starostina, Alexey M. Zadorozhny, Anastasiya A. Isaeva, Valentina S. Nesmeyanova, Daniil V. Shanshin, Konstantin O. Baranov, Natalya V. Volkova, Boris N. Zaitsev, Lyubov A. Orlova, Anna V. Zaykovskaya, Oleg V. Pyankov, Elena D. Danilenko, Sergei I. Bazhan, Dmitry N. Shcherbakov, Alexander V. Taranin, Alexander A. Ilyichev
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 4; Pages: 2188
Despite the fact that a range of vaccines against COVID-19 have already been created and are used for mass vaccination, the development of effective, safe, technological, and affordable vaccines continues. We have designed a vaccine that combines the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed741d81dc6147c80039e712d897b7e9
https://pubmed.ncbi.nlm.nih.gov/35216301
https://pubmed.ncbi.nlm.nih.gov/35216301
Autor:
Irina S Shulgina, Ekaterina V Starostina, I. V. Kolosova, Alexey M Zadorozhny, Stanislav N Yakubitskiy, Mariya B Borgoyakova, Stepan A. Pyankov, Ksenia A Titova, Alexander A. Sergeev, Sergei N. Shchelkunov, Larisa I. Karpenko, Denis N Kisakov
Publikováno v:
Viruses
Volume 13
Issue 8
Viruses, Vol 13, Iss 1631, p 1631 (2021)
Volume 13
Issue 8
Viruses, Vol 13, Iss 1631, p 1631 (2021)
Mass vaccination has played a critical role in the global eradication of smallpox. Various vaccinia virus (VACV) strains, whose origin has not been clearly documented in most cases, have been used as live vaccines in different countries. These VACV s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e280deea4713e256459c5f4f65986cfe
https://pubmed.ncbi.nlm.nih.gov/34452494
https://pubmed.ncbi.nlm.nih.gov/34452494